EZH2 and metastatic malignant neoplasm in the lymph nodes: In addition, EZH2 expression and KRAS mutation significantly correlated with the occurrence of lymph node metastasis (p = 0.0003 and p = 0.0052, respectively) and poor differentiation grade (p < 0.0001 and p = 0.035) as shown in Table 2.